Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.
This study has been terminated.
(The reason for termination was lack of tolerability and efficacy of the combination treatment)
Information provided by (Responsible Party):
First received: November 18, 2010
Last updated: May 5, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||April 23, 2015|
|Primary Completion Date:||January 30, 2014 (Final data collection date for primary outcome measure)|